Peter Nørgaard
Impact in
Papers in
- Oncology 39
- Viral-associated cancers and disorders 8
- Cancer-related Molecular Pathways 8
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 4
-
- Lymphoma Diagnosis and Treatment 28
- Co-authors
- Mogens Spang‐Thomsen (8 shared papers)Hans Skovgaard Poulsen (8 shared papers)Brian K. Law (10 shared papers)Harold L. Moses (6 shared papers)Anne Ortved Gang (20 shared papers)Mette Ølgod Pedersen (17 shared papers)Tim Svenstrup Poulsen (13 shared papers)Kjeld Søballé (1 shared paper)
- Journals
- Blood (9 papers)European Journal Of Haematology (6 papers)Hematological Oncology (5 papers)Journal of Biological Chemistry (3 papers)British Journal of Cancer (3 papers)
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Peter Nørgaard
73 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 129
- Oncology 785
- Genetics 254
- Pathology and Forensic Medicine 388
- Molecular Biology 707
- Immunology 195
Countries citing papers authored by Peter Nørgaard
This map shows the geographic impact of Peter Nørgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Nørgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Nørgaard more than expected).
Fields of papers citing papers by Peter Nørgaard
This network shows the impact of papers produced by Peter Nørgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Nørgaard. The network helps show where Peter Nørgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Nørgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 131 | |
| 2 | 1997 | 110 | |
| 3 | 2013 | 92 | |
| 4 | 2012 | 77 | |
| 5 | 1986 | 64 | |
| 6 | 2012 | 63 | |
| 7 | 2000 | 63 | |
| 8 | 2009 | 63 | |
| 9 | 1995 | 62 | |
| 10 | 1999 | 57 | |
| 11 | 2014 | 57 | |
| 12 | Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. | 1999 | 55 |
| 13 | 2014 | 48 | |
| 14 | 2014 | 45 | |
| 15 | 1994 | 41 | |
| 16 | 1999 | 41 | |
| 17 | 1996 | 40 | |
| 18 | 2000 | 40 | |
| 19 | 1989 | 34 | |
| 20 | 2008 | 26 |
About Peter Nørgaard
Peter Nørgaard is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Genetics and Immunology, having authored 78 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (16 papers), Viral-associated cancers and disorders (8 papers), Cancer-related Molecular Pathways (8 papers), TGF-β signaling in diseases (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (785 citations), Genetics (254 citations), Pathology and Forensic Medicine (388 citations), Molecular Biology (707 citations) and Immunology (195 citations). Peter Nørgaard has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Mogens Spang‐Thomsen, Hans Skovgaard Poulsen, Brian K. Law, Harold L. Moses, Anne Ortved Gang, Mette Ølgod Pedersen, Tim Svenstrup Poulsen, Kjeld Søballé, Ivan Hvid and Signe Ledou Nielsen. Their work appears in journals such as Blood, European Journal Of Haematology, Hematological Oncology, Journal of Biological Chemistry and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.